David R. Bauer
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/25898_drbauer.jpg?itok=Y1b0J_im)
Filters
Stanley Black & Decker $750 million notes offering
The investment-grade notes are due 2026 and 2028
European Biotech Acquisition $220 million combination with Oculis
We advised European Biotech Acquisition on its de-SPAC transaction
Ankura Consulting Group acquisition of Chartwell Compliance
We advised Ankura Consulting Group on the transaction
Arrow Electronics $500 million senior notes offering
The 6.125% investment-grade senior notes are due 2026
Eli Lilly $4 billion notes offering
The investment-grade notes are due 2026, 2033, 2053 and 2063
Intel $11 billion senior notes offering
The investment-grade offering comprises seven tranches of notes
CureVac $250 million follow-on offering
We advised CureVac on the equity offering
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market